SG Americas Securities LLC acquired a new stake in shares of agilon health, inc. (NYSE:AGL – Get Rating) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 7,935 shares of the company’s stock, valued at approximately $173,000.
Other institutional investors also recently bought and sold shares of the company. Stratos Wealth Partners LTD. raised its position in agilon health by 1.3% in the second quarter. Stratos Wealth Partners LTD. now owns 38,554 shares of the company’s stock worth $842,000 after acquiring an additional 500 shares during the period. Cambridge Investment Research Advisors Inc. raised its position in shares of agilon health by 1.6% during the second quarter. Cambridge Investment Research Advisors Inc. now owns 36,478 shares of the company’s stock valued at $796,000 after buying an additional 561 shares during the last quarter. Treasurer of the State of North Carolina grew its stake in agilon health by 1.6% during the first quarter. Treasurer of the State of North Carolina now owns 61,489 shares of the company’s stock valued at $1,559,000 after acquiring an additional 980 shares in the last quarter. Level Financial Advisors Inc. bought a new stake in agilon health in the 2nd quarter valued at $25,000. Finally, First Horizon Advisors Inc. increased its holdings in shares of agilon health by 772.7% in the first quarter. First Horizon Advisors Inc. now owns 1,213 shares of the company’s stock worth $31,000 after purchasing an additional 1,074 shares during the last quarter.
agilon health Stock Performance
AGL stock opened at $18.98 on Friday. The firm has a 50-day simple moving average of $21.67 and a two-hundred day simple moving average of $21.66. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.48 and a current ratio of 2.48. agilon health, inc. has a one year low of $14.36 and a one year high of $28.36. The firm has a market cap of $7.82 billion, a price-to-earnings ratio of -73.00 and a beta of 0.93.
Insider Buying and Selling
Wall Street Analysts Forecast Growth
Several equities research analysts have recently weighed in on AGL shares. Wells Fargo & Company increased their price target on agilon health from $23.00 to $28.00 and gave the stock an “overweight” rating in a report on Monday, August 8th. SVB Leerink reduced their price objective on agilon health from $33.00 to $30.00 and set an “outperform” rating on the stock in a report on Friday, November 4th. Truist Financial lowered their target price on agilon health from $33.00 to $29.00 and set a “buy” rating for the company in a report on Wednesday, September 7th. The Goldman Sachs Group initiated coverage on agilon health in a research note on Monday, September 12th. They set a “buy” rating and a $38.00 price target on the stock. Finally, TheStreet lowered shares of agilon health from a “c-” rating to a “d+” rating in a research note on Thursday, August 18th. One analyst has rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $30.57.
agilon health Company Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.
- Get a free copy of the StockNews.com research report on agilon health (AGL)
- MarketBeat: Week in Review 11/7 – 11/11
- Oil Is a Compelling Reason The Sell-Off In Stocks Isn’t Over
- Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
- Six Flags is a Ride You Don’t Want to Get Stuck On
- Hanesbrands May be Signaling a Bad Week for Retail Stocks
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.